ReviewCancer management and research2017

Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives.

Joelle El-Amm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.